Q2 2024 Holdings
Filed 2024-08-09 | 82 holdings | $1.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Invesco QQQ TR(QQQ)Put | UNIT SER 1 | 46090E103 | $191.6M | 400,000 | 10.0% |
| Natera Inc(NTRA) | COM | 632307104 | $167.9M | 1,550,280 | 8.7% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $101.1M | 2,793,987 | 5.3% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $100.1M | 734,284 | 5.2% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $92.7M | 649,541 | 4.8% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $66.9M | 724,225 | 3.5% |
| Stryker Corporation(SYK) | COM | 863667101 | $65.7M | 193,084 | 3.4% |
| AstraZeneca PLC(AZN) | SPONSORED ADR | 046353108 | $62.5M | 801,417 | 3.2% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $57.4M | 1,625,703 | 3.0% |
| Align Technology Inc(ALGN) | COM | 016255101 | $52.8M | 218,524 | 2.7% |
| Edwards Lifesciences Corp(EW)Put | COM | 28176E108 | $46.2M | 500,000 | 2.4% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $45.4M | 1,951,562 | 2.4% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $44.2M | 2,153,669 | 2.3% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $41.3M | 2,864,250 | 2.1% |
| Abbott Labs(ABT)Call | COM | 002824100 | $40.5M | 390,200 | 2.1% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $40.4M | 1,151,528 | 2.1% |
| Intuitive Surgical Inc(ISRG) | COM | 46120E602 | $38.8M | 87,217 | 2.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $35.9M | 147,929 | 1.9% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $33.1M | 1,861,277 | 1.7% |
| Arrivent BioPharma Inc(AVBP) | COM | 04272N102 | $31.5M | 1,696,752 | 1.6% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $31.1M | 63,862 | 1.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $30.9M | 195,852 | 1.6% |
| Y-mAbs Therapeutics Inc(YMABUSD) | COM | 984241109 | $26.5M | 2,194,278 | 1.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $25.0M | 310,198 | 1.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $23.4M | 2,773,286 | 1.2% |
| Spdr Ser Tr(XBI)Put | S&P BIOTECH | 78464A870 | $23.2M | 250,000 | 1.2% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $22.6M | 554,359 | 1.2% |
| Intuitive Surgical Inc(ISRG)Put | COM | 46120E602 | $22.2M | 50,000 | 1.2% |
| Savara Inc(SVRA) | COM | 805111101 | $21.6M | 5,358,918 | 1.1% |
| Celldex Therapeutics Inc(CLDX) | COM | 15117B202 | $20.3M | 547,707 | 1.1% |
| Roivant Sciences Ltd(ROIV) | SHS | G76279101 | $19.7M | 1,868,412 | 1.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $19.5M | 429,244 | 1.0% |
| Inozyme Pharma Inc | COM | 45790W108 | $19.1M | 4,280,308 | 1.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $17.7M | 455,099 | 0.9% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $17.0M | 825,243 | 0.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $15.3M | 227,747 | 0.8% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $13.2M | 171,080 | 0.7% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $12.4M | 44,417 | 0.6% |
| Insulet Corp(PODD) | COM | 45784P101 | $12.3M | 60,967 | 0.6% |
| Alnylam Pharmaceuticals Inc(ALNY)Call | COM | 02043Q107 | $12.2M | 50,000 | 0.6% |
| Pharvaris N V(PHVS) | COM | N69605108 | $11.3M | 601,534 | 0.6% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $10.1M | 150,490 | 0.5% |
| Immatics N.v(IMTX) | SHS | N44445109 | $9.3M | 796,704 | 0.5% |
| Cabaletta Bio Inc(CABA) | COM | 12674W109 | $9.1M | 1,220,400 | 0.5% |
| PepGen Inc(PEPG) | COM | 713317105 | $9.0M | 561,128 | 0.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $8.6M | 475,691 | 0.4% |
| Immunome Inc(IMNM) | COM | 45257U108 | $7.9M | 655,680 | 0.4% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $7.7M | 181,828 | 0.4% |
| Inari Med Inc(NARIUSD) | COM | 45332Y109 | $7.5M | 155,838 | 0.4% |
| Dexcom Inc(DXCM) | COM | 252131107 | $7.0M | 61,494 | 0.4% |